Altered cytokine profiles in relapsed paucibacillary leprosy: a case report

[1]  Elisa M. Tjon Kon Fat,et al.  Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia , 2018, Scientific Reports.

[2]  Publisher's Note , 2018, Anaesthesia.

[3]  R. A. van den Berg,et al.  Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans , 2017, Front. Immunol..

[4]  Perdomo-CelisFederico,et al.  Levels of Circulating Tumor Necrosis Factor-α in Children with Symptomatic Dengue Evaluated by ELISA and Bead-Based Assays. , 2017 .

[5]  D. Thappa,et al.  Chapter-39 Relapse in Leprosy , 2017 .

[6]  F. Perdomo-Celis,et al.  Levels of Circulating Tumor Necrosis Factor-α in Children with Symptomatic Dengue Evaluated by ELISA and Bead-Based Assays. , 2017, Viral immunology.

[7]  V. Ramesh,et al.  Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6 , 2016, PLoS neglected tropical diseases.

[8]  E. Sarno,et al.  Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse , 2015, PloS one.

[9]  S. Reed,et al.  Rapid Quantitative Serological Test for Detection of Infection with Mycobacterium leprae, the Causative Agent of Leprosy , 2013, Journal of Clinical Microbiology.

[10]  V. Ramesh,et al.  CD4+ Th17 Cells Discriminate Clinical Types and Constitute a Third Subset of Non Th1, Non Th2 T Cells in Human Leprosy , 2013, PLoS neglected tropical diseases.

[11]  Sang-Nae Cho,et al.  New Biomarkers with Relevance to Leprosy Diagnosis Applicable in Areas Hyperendemic for Leprosy , 2012, The Journal of Immunology.

[12]  B. Kumar,et al.  IAL Textbook of Leprosy , 2010 .

[13]  G. Ireton,et al.  Use of Protein Antigens for Early Serological Diagnosis of Leprosy , 2007, Clinical and Vaccine Immunology.

[14]  Kazuo Kobayashi,et al.  Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. , 2007, FEMS microbiology letters.

[15]  N. Ishii,et al.  Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae. , 2005, Cellular immunology.

[16]  N. Ishii,et al.  Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens. , 2003, Cellular immunology.

[17]  The final push strategy to eliminate leprosy as a public health problem: questions and answers. , 2002, Leprosy review.

[18]  E. Sampaio,et al.  Immunological Cytokine Correlates of Protective Immunity and Pathogenesis in Leprosy , 2000, Scandinavian journal of immunology.

[19]  P. Klatser,et al.  A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. , 1998, The American journal of tropical medicine and hygiene.

[20]  M. Becx-Bleumink.  Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses. , 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[21]  D. Anandan,et al.  Evaluation of MLPA test for the serodiagnosis of leprosy. , 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[22]  Y. Nishimura,et al.  Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field , 1990, Journal of clinical microbiology.